Ninety-day Readmission and Long-Term Mortality in Medicare Patients (≥65 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium)

Ticagrelor and prasugrel were found to be superior to clopidogrel for the treatment of acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI); however, the comparative effectiveness of these 2 drugs remains unknown. We compared post-discharge outcomes among older patients treat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Cardiol
Autori principali: Song, Chris, Sukul, Devraj, Seth, Milan, Dupree, James M., Khandelwal, Akshay, Dixon, Simon R., Wohns, David, LaLonde, Thomas, Gurm, Hitinder S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850017/
https://ncbi.nlm.nih.gov/pubmed/29025684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2017.08.009
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi